Missouri Proteomics Study IDs Signaling Networks as Potential Drug Targets in Brain Metastasis
July 29, 2011
Missouri Proteomics Study IDs Signaling Networks as Potential Drug Targets in Brain Metastasis
The study identified 12 proteins that differentiated brain-targeting metastatic cells from a broadly metastatic parental cell line and identified signaling networks involved in this metastasis, suggesting the need for new treatment paradigms.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.